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Abstract Five loci for restless legs syndrome (RLS) on
chromosomes 12q, 14q, 9p, 2q, and 20p (RLS1-RLS5)
have been mapped in RLS families, with a recessive in the
first and autosomal-dominant mode of inheritance in the
latter cases. Investigations of further RLS families showed
evidence for genetic locus heterogeneity. We have con-
ducted a genome-wide linkage analysis in a large RLS
family of Italian origin with 12 affected members in 3
generations using 5,861 single nucleotide polymorphisms
(SNP, 6K Illumina). Linkage analysis was performed under
an autosomal-dominant model with a complete penetrance,
an allele frequency of 0.003 and a phenocopy rate of 0.005.
The genome-wide scan resulted in suggestive evidence for
linkage on chromosome 19p with maximum multipoint
logarithm of the odds score of 2.61 between markers
rs754292 and rs273265. The locus was replicated in a
family-based association study in a set of 159 trios of
European origin. This study provides evidence for a further
RLS locus, thus supporting the picture of RLS as a
genetically heterogenous complex trait.
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Restless legs syndrome (RLS; MIM 102300) is a neuro-
logical disorder, which is diagnosed by the presence of four
essential criteria consisting of: (1) an urge to move the limbs
with uncomfortable sensation and (2) a worsening during
rest and/or inactivity. These symptoms are typically (3)
alleviated by moving the affected extremity and are, at least
initially, exclusively present (4) in the evening or at night
[1]. Further features supporting the diagnosis are a positive
family history, a clear response to dopaminergic treatment,
and the presence of periodic limb movements (PLM) during
wakefulness or sleep [1]. In its fully developed form, the
disease causes disturbance of sleep onset and duration.
Up to 60% of RLS patients report a positive family
history [2, 3]. To date, five loci on chromosomes 12q, 14q,
9p, 2q, and 20p (RLS1-RLS5) have been identified in RLS
families. The parametric linkages were based on a recessive
[4] and dominant mode of inheritance in the latter cases [5–
8]. RLS1 and RLS2 could be confirmed in families of
French Canadian origin [9, 10] and RLS1 and RLS3 in
families of German origin [11, 12]. In addition, RLS2 was
replicated in a family-based association study [13]. How-
ever, several RLS families did not show linkage to any of
RLS1, RLS2, and RLS3 loci, and there is evidence for
further genetic locus heterogeneity in RLS [9, 11].
We have performed a genome-wide linkage analysis in a
three-generation RLS family identifying a new locus for
RLS on chromosome 19p and investigated this locus by an
independent, family-based association study.
Materials and methods
Subjects
EU-RLS-GENE sample and family RLS_B008
EU-RLS-GENE is a study of the European RLS Study
group aiming to identify the genetics of RLS by means of a
multicenter design. Experts for RLS of 14 centers in
8 European countries are collecting RLS families (sib-pairs,
trios, and expanded families) in a prospective manner since
2003. The subjects were investigated using a standardized
clinical assessment. This consisted of a personal question-
naire-based interview to ascertain the diagnosis according
to mandatory criteria and also implementing clinical
description of the symptoms, e.g., age-at-onset, drug
response, and severity. Polysomnographic examinations
are not obligatory for the diagnosis of RLS and therefore
not required for inclusion of a patient into the study. All
participating research centers have acquired approval of
their local ethical committee, and subjects of the study have
signed an informed consent. Genomic DNA of all indi-
viduals is being centrally isolated and stored at the Institute
of Human Genetics, Munich. The family B008 of Italian
origin was selected from the set of pedigrees gathered
within the EU-RLS-GENE project as one of three most
promising to produce a significant logarithm of the odds
(LOD) score when performing a genome-wide scan.
Genotyping
Genomic DNA was extracted from peripheral blood using
standard protocols. A genome-wide scan was performed
with the Illumina Linkage Panel IV (Illumina, 9885 Towne
Center Drive, San Diego, CA, 92121–1975, USA) consist-
ing of 5,861 single nucleotide polymorphism (SNP)
markers in an average distance of 0.64 cM. All reactions
were performed according to the manufacturer’s recom-
mendations. Fluorescence signals were scanned using
Illumina Bead-station. Allele calls were visually checked
by an experienced scientist. According to the results of the
Table 1 Microsatellite markers on chromosomes 19p and 10p used in
association analysis
Marker MB CM Alleles Study
Chromosome 19p
D19S221 12573742 36.220 11 L, A
D19S840 13701918 37.940 10 L, A
D19S226 14494400 42.280 16 L, A
D19S411 15763094 42.281 11 L, A
D19S917 16222017 43.340 17 L, A
D19S930 16829233 44.410 17 L, A
D19S410 17258335 45.480 13 L, A
D19S579 17437565 45.485 6 L
D19S429 17496924 45.488 4 L
D19S915 17778874 47.305 6 L
D19S212 18204060 47.308 8 L
D19S895 18614110 47.310 13 L, A
D19S414 36606564 54.010 5 L
Chromosome 10p
D10S189 6761880 19.000 7 L, A
D10S1691 7351613 21.460 16 L, A
D10S1172 8205131 22.280 25 L, A
D10S1728 8798238 27.190 9 L, A
D10S1720 9114076 27.195 10 L, A
D10S465 9324319 28.310 7 L, A
D10S547 10590416 29.150 12 L, A
Markers are sorted according to their genetic positions.
MB Physical positionaccording totheMay2004assembly;CM genetic
position from Marshfield sex-averaged map; Alleles observed number
of alleles in our study; Study L linkage study, A association study
76 Neurogenetics (2008) 9:75–82genome-wide scan (see below), 13 additional microsatellite
markers on chromosome 19p spanning 11 cM (6 Mbp) and
7 markers on chromosome 10p spanning 10 cM (3.8 Mbp;
Table 1) were subsequently genotyped to confirm the SNP
genotyping and narrow down the positive candidate regions
obtained from the genome-wide scan. In addition, eight and
seven of these evenly distributed microsatellite markers
were selected on chromosomes 19p and 10p, respectively,
to genotype the EU-RLS-GENE trios. Primer information
was derived from GDB (GDB; www.gdb.org); the genetic
distances were obtained from the Marshfield map (http://
research.marshfieldclinic.org/genetics/)[ 14]. The physical
Fig. 1 Pedigree structure of
family B008 and haplotype re-
construction at locus 19p13. The
haplotypes correspond to
microsatellite loci described in
Table 1. The alleles written in
bold were inferred, 0 marks
unavailable alleles, x sites of
recombination. Haplotypes
shared by all affected patients
and not present in unaffected are
marked by the box. The DNA
from individual “2” was not
available
Fig. 2 Results of linkage
analysis–genome-wide scan in
the family. The graph represents
multipoint LOD scores under
the autosomal dominant mode
of inheritance. Each point cor-
responds to one SNP marker, all
autosomes are represented.
The LOD scores below −3 are
truncated
Neurogenetics (2008) 9:75–82 77positions were obtained from UCSC genome browser
(http://genome.ucsc.edu, assembly May 2004) [15]. The
polymerase chain reaction amplification products were
diluted, pooled, and finally electrophoresed under denaturing
conditions on an ABI 3730 sequencer. After an automatic
allele calling by the Genemapper 3.5 software (Applied
Biosystems, Foster City, CA, USA), every genotype was
verified manually by an experienced scientist.
Linkage analysis
The genotypes of SNP markers were analyzed by multi-
point parametric linkage test implemented in Merlin 0.10.2
[16] scoring all relationships in the pedigree. The paramet-
ric linkage analysis in the putative region was performed
using GeneHunter 2.1 [17]. Simulations for the maximum
expected LOD score for family B008 were calculated by the
Slink package using 10,000 permutations [18, 19]. Param-
eters used were an allele frequency of 0.003, complete
penetrance for homo- and heterozygotes, and a phenocopy
rate of 0.005, thus implying an autosomal-dominant disease
model in accordance with a previous segregation analysis
[20]. All marker genotypes were checked for Mendelian
inconsistencies using PedCheck program v1.1 [21].
Association analysis
The general approach in our family-based association study
was the transmission disequilibrium test (TDT). For single
markers, we used an algorithm suitable for multiallelic
markers implemented in ETDT 2.5 software package [22].
Two results are produced: (1) an allele-wise and (2) a
genotype-wise association (including a test for goodness-of-
fit of the latter). An allele-wise statistic assumes an allele-
specific effect on transmission distortion from heterozygous
parents and genotype-wise statistic allows an independent
effect for each parental genotype [23]. The affection status of
the parents is ignored in both cases. The test is positive in the
presence of both linkage and association of the marker and
the disease. All resulting p values <0.05 were retested using
Monte-Carlo empirical estimation by 1,000 permutations, p
values <0.01 by 10,000 permutations [23]. The TDTPHASE
routine of UNPHASED 2.403 package [24] was employed
to generate haplotypes formed by two neighboring markers
according to genetic positions, to perform the TDT, and to
Fig. 3 LOD plot on chromo-
somes 19p. Multipoint parame-
tric LOD score for family B008
on chromosome 19p between
microsatellite markers D19S221
and D19S414. Markers
D19S212 and D19S895 share
the same genetic position with
marker D19S915, marker
D19411 with D19S226, and
markers D19S579 and D19S429
with D19S410. Names of these
markers are not displayed and
the presenting markers are la-
beled with plus symbol
Fig. 4 LOD plot on chromosomes 10p. Multipoint parametric LOD
score for family B008 on chromosome 10p between microsatellite
markers D10S189 and D10S547
78 Neurogenetics (2008) 9:75–82asses the empirical significance level by 1,000 permutations.
Independently, the same haplotypes were reconstructed using
GeneHunter 2.1 [17], recoded and computed also using
ETDT 2.5 to make genotype-wise results available.
Sequencing
Coding regions of two candidate genes RAB3A and KCNN1
mapping within the chromosome 19p association region
were sequenced in three family members of B008. Primers
for exons including adjacent splice sites were designed using
the program ExonPrimer (http://ihg.gsf.de). Sequencing
was performed with the BigDye terminator chemistry 3.1
(ABI) on an ABI3730 sequencer. Sequencing analysis was




From 17 family members (11 women and 6 men; mean age,
48.7 years±SD 13.7) in three generations DNAwas available
(Fig. 1). Twelve were classified as affected (8 women and
4 men; average age at onset of symptoms, 35.1 years±SD
10.2).
EU-RLS-GENE sample
Of the EU-RLS-GENE sample, 159 trios (107 women and
52 men) of 87 RLS families with a total of 362 family
members were selected. Of these, 273 were RLS affected,
(176 women; mean age, 48.5 years, SD±17.16; average age-
Table 2 Single marker and haplotype results of the association analysis
Marker/haplotype Tabular p Empirical p Method Family subset
D19S221–D19S840 0.00120 0.0260 TDTPHASE All
D19S840–D19S226 0.00245 0.0210 TDTPHASE All
D19S226–D19S411 0.00139 0.0270 Allele-wise All
D19S917–D19S930 0.00222 0.0150 Genotype-wise All
D19S930 0.01128 0.0260 Allele-wise All
D19S930–D19S410 0.00147 0.0030 TDTPHASE All
D19S410 0.01955 0.0230 Allele-wise All
D19S410–D19S895 0.00012 0.0060 TDTPHASE All
D19S840–D19S226 0.00391 0.0400 TDTPHASE Central Europe
D19S226–D19S411 0.00004 0.0050 Genotype-wise Central Europe
D19S930 0.01074 0.0170 Allele-wise Central Europe
D19S930–D19S410 0.00098 0.0170 Genotype-wise Central Europe
D19S410 0.03645 0.0460 Allele-wise Central Europe
D19S840 0.01327 0.0370 Genotype-wise South Europe
D19S917–D19S930 0.00025 0.0110 TDTPHASE North Europe
D19S930–D19S410 0.00059 0.0280 Genotype-wise North Europe
D10S1172 0.00223 0.0117 Genotype-wise Central Europe
Tabular p Significance according to the χ
2 and corresponding number of degrees of freedom; Empirical p values obtained by permutation
analysis; Method type of analysis which produced the p values. Allele-wise and genotype-wise refer to ETDT 2.5, TDTPHASE means that the best
p value was obtained by this program; Family subset the origin of families, where the association was found; All refers to all families combined
Fig. 5 Best p values obtained.
The empirical p values are dis-
played as their negative decimal
logarithm. Values at the marker
positions correspond to single
marker results; values between
markers represent results ob-
served in the corresponding
haplotypes in-between
Neurogenetics (2008) 9:75–82 79at-onset of symptoms, 26.3 years, SD±14.63). The trios
originated from North Europe (76, Finland), Central Europe
(52, Germany, Austria, and Czech Republic), and South
Europe (31, Italy and Greece).
Linkage analysis
The results of the genome-wide scan in family B008 are
summarized in Fig. 2. Multipoint parametric linkage analysis
identified a region on chromosome 10p with a LOD score of
1.06 with a peak at marker rs1537632 and on chromosome
19p with a LOD score of 2.61 between markers rs754292
and rs273265. The maximum LOD score obtained during
simulations was 2.74 under the assumption of an autosomal
dominant model and multiallelic microsatellite marker.
Finemapping with microsatellite markers on chromosome
10p revealed a multipoint LOD score of 1.11 at marker
D10S1728. On chromosome 19p, the maximum multipoint
LOD score of 2.57 was observed between markers D19S429
and D19S915, which are 1.9 cM (300 kbp) apart. The LOD
score plots across these regions are shown in Figs. 3 and 4.
Association analysis
Significant associations (defined as empirical p<0.01) were
found on chromosome 19p in the entire sample of 159 trios
for the two neighboring haplotypes D19S930–D19S410
and D19S410–D19S895. For the haplotype D19S930–
D19S410, suggestive evidence of association (defined as
empirical p<0.05) was also detected in trio subsets of both
North and Central European populations. These results are
supported by suggestive associations for the two single
markers D19S930 and D19S410 in the entire trio set and in
the Central European subset. Another significant associa-
tion with haplotype D19S226–D19S411 was found in
families of Central European origin, which is supported
by a suggestive association in the entire trio set.
On chromosome 10p, only one single marker (D10S1172)
showed a suggestive association result in the Central
European trio subset, but no marker or haplotype reached
significant level for association. The significant and sugges-
tive results for both chromosomes are summarized in Table 2.
The best obtained p values across the region of chromosome
19p are displayed in Fig. 5.
Sequencing of the genes
All 11 exons of the KCNN1 gene and all 5 exons in RAB3A
were analyzed including the splice-sites. The last exons of
both genes were sequenced in two overlapping segments.
For all analyzed DNA regions, both strands were indepen-
dently sequenced. No mutation was found within the exons
of the two studied genes when comparing the three affected
members of the B008 family (24770, 24774, and 24777) to
the reference sequence and one negative control.
Discussion
This study provides for the first time suggestive evidence
for linkage of RLS to chromosome 19p13 in an Italian RLS
family using a genome-wide approach. This finding
presents one further susceptibility locus for RLS, mapped
within a 1.9 cM (0.3 Mbp) interval between markers
D19S429 and D19S915. In addition, the linkage to
chromosome 19p was confirmed in an independent Euro-
pean trio sample. Given the positive results of family-based
association analysis, we see the replication achieved. The
statistical methods and the study design used in the rep-
lication (TDT analysis) are robust to misspecification of the
genetic model and also are able to accommodate commonly
encountered problems in phenotypes with a high preva-
lence, such as intrafamilial heterogeneity and bilinearity.
Considering the results of the linkage analysis, we are
aware of the fact that the parametric LOD scores for
chromosome 19p are below the usually adopted threshold
for a Mendelian trait (i.e., a LOD>3). However, we have
not observed even a simulated result above this threshold,
and the actual resulting LOD score is close to the maximal
simulated value. There is a common haplotype shared by
the majority of affected individuals (Fig. 5), and in the
remaining two members, there is a recombination between
the same two microsatellite markers. Thus, each of these
two patients carries a different part of the haplotype. The
putative 1.9 cM region is possibly a recombination hot-spot
(as it is only 282 kbp physically long) and contains no more
microsatellite markers.
Fig. 6 Physical positions of mapping signals in the family B008. The
critical region was delimited by following mapping approaches: (1)
genome-wide SNP panel, (2) regional microsatellite marker fine-
mapping, (3) association (TDT) and (4) sequencing of candidate
genes. The lines indicate the length of chromosomal regions or genes
investigated
80 Neurogenetics (2008) 9:75–82There are multiple genes annotated within the critical
region. Sequencing of the two candidate genes RAB3A and
KCNN1, selected on the assumed pathophysiology of RLS
and location within the association region, did not identify
any mutation (Fig. 6). However, variants in the promoter
region or in intronic regulatory elements cannot be ruled
out. RAB3A is involved in process of exocytosis of
neurotransmitters [26]. RAB3A knockout mice showed
abnormal regulation of circadian rhythm and sleep–wake
cycle-related activity [26]. KCNN1 codes for a small
conductance calcium-gated potassium channel, which reg-
ulates neuronal excitability by contributing to the slow
component of synaptic after hyperpolarization [27].
Another strategy for the detection of genetic determi-
nants involved in RLS pathogenesis is the genome-wide
population-based association study using SNP markers. A
genome-wide study in the German and Canadian popula-
tion revealed association to intronic or intergenic variants in
MEIS1, BTBD9, and third locus encoding LBXCOR1 and
MAP2K5 [28]. A similar study in the Icelandic population
showed association of periodic limb movements with
BTBD9 [29]. These genes are known to be involved in
embryonic development of the central nervous system.
For future identification of genetic risk variants for RLS
linkage and association studies should be used as comple-
mentary strategies. The knowledge of linkage peaks can be
implemented in association study designing, e.g., by
lowering the threshold for replication within these regions.
A further possibility could include computational methods
using the knowledge of the clinical description of the
disease and the putative genetic region as an input for the
selection of candidate genes [30].
To summarize, we have shown evidence for a new
susceptibility locus for RLS on chromosome 19p. The
finding was replicated in a family-based association study.
Inclusion of this locus in future analyses will increase
probability for the detection of further genetic determinants
of RLS.
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